Search results for: 'recombinant human carboxypeptidase n subunit 2 cpn2 eb pb8hu6024'
- Product Name
- Organism
- Tag (Tag info)
- Expression Host (Source)
- Did you mean
- recombinant human carboxypeptidase n subunit 2 cdna eb pb8hu6024
- recombinant human carboxypeptidase n subunit 2 cani eb pb8hu6024
- Related search terms
- recombinant human carboxypeptidase n subunit 2 cat eb pe8hu6024b
- recombinant human carboxypeptidase n subunit 2 cani eb pe8hu6024
- recombinant human carboxypeptidase n subunit 2 cat eb pb8hu6024
- recombinant human carboxypeptidase n subunit 2 cdna eb pb8hu6024
- human laminin 500 proteus research goods
-
Anti-Human FGFR2 (Bemarituzumab)HumanN/ACHO
Various size from 1 mg to 161 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human GPC3 (Codrituzumab)HumanN/ACHO
Various size from 1 mg to 163 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human HER2 (Margetuximab)HumanN/ACHO
Various size from 1 mg to 164 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human LOXL2 (Simtuzumab)HumanN/ACHO
Various size from 1 mg to 172 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human MSLN (Amatuximab)HumanN/ACHO
Various size from 1 mg to 173 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human FcRn (Nipocalimab)HumanN/ACHO
Various size from 1 mg to 174 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human FcRn (Rozanolixizumab)HumanN/ACHO
Various size from 1 mg to 175 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human CD20 (Rituximab)HumanN/ACHO
Various size from 1 mg to 176 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human CD137 (Urelumab)HumanN/ACHO
Various size from 1 mg to 177 mg available. Please inquiry us first for the price and availablity.
-
Anti-Human TACSTD2 (Sacituzumab)HumanN/ACHO
Various size from 1 mg to 179 mg available. Please inquiry us first for the price and availablity.